Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation
Michael P. Schön(Universitätsmedizin Göttingen), Wolf‐Henning Boehncke(University Hospital of Geneva), Roland Kaufmann(Robert Koch Institute), Harald Gollnick(University Hospital Magdeburg), Thomas M. Zollner(Bayer (Germany)), Thomas Krahn(Bayer (Germany)), Christina M. Parker(Brigham and Women's Hospital), Maria-L. Rodriguez(Bayer (Germany)), Kerstin Henninger(Bayer (Germany)), Matthias Schramm(Bayer (Germany)), Margarete Schön(Otto-von-Guericke-Universität Magdeburg), K. D. Bremm(Bayer (Germany)), Horst Antonicek(Bayer (Germany)), Ralf J. Ludwig(University of Lübeck), J. E. Schultz(Goethe University Frankfurt), Erwin Bischoff(Bayer (Germany))
Cited by 129
Related Papers
New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group
|Journal of the American Academy of Dermatology|2009|835
Management of Acne
|Journal of the American Academy of Dermatology|2003|818
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
|BMC Cancer|2012|561
European Evidence‐based (S3) Guidelines for the Treatment of Acne
|Journal of the European Academy of Dermatology and Venereology|2012|422